Belinostat

• Description:

  Belinostat is a novel hydroxamic acid-type histone deacetylase (HDAC) inhibitor with antineoplastic activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  318.35

• Molecular Formula:

  C15H14N2O4S

• Notes:

  Research use only, not for human use.

• Receptor:

  HDAC

• CAS Number:

  414864-00-9